Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters











Database
Language
Publication year range
1.
Acta Cir Bras ; 28(1): 5-9, 2013 Jan.
Article in English | MEDLINE | ID: mdl-23338107

ABSTRACT

PURPOSE: To compare fluid replacement therapy with Hydroxyethyl starch 6% (HES) versus Ringer's lactate (RL) in a rodent model of non-septic renal ischemia. METHODS: Forty male Wistar rats were randomized to receive HES 2 ml.kg(-1).hr(-1) or RL 5 ml.kg(-1).hr(-1) that underwent 30 minutes of renal ischemia followed by reperfusion. Twelve hours after kidney ischemia, the kidneys were evaluated for histological changes. Serum NGAL levels were obtained at different times of the experimental protocol. RESULTS: Rodents in the HES group had a median (IQR) grade of renal injury 3 (3 to 5) compared to 2 (2 to 4) in the RL group (p=0.03). NGAL levels were not associated with the severity of kidney injury. CONCLUSION: Hydroxyethyl starch administration caused more kidney injury than Ringer's lactate in a non-infectious model of renal hypoperfusion.


Subject(s)
Acute Kidney Injury/therapy , Hydroxyethyl Starch Derivatives/therapeutic use , Ischemia/therapy , Isotonic Solutions/therapeutic use , Kidney/blood supply , Plasma Substitutes/therapeutic use , Acute Kidney Injury/pathology , Acute-Phase Proteins , Animals , Fluid Therapy/methods , Hemodynamics , Ischemia/pathology , Kidney/pathology , Lipocalin-2 , Lipocalins/blood , Male , Oncogene Proteins/blood , Random Allocation , Rats , Rats, Wistar , Reproducibility of Results , Ringer's Lactate , Time Factors , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL